Short Term Trading Week Starting: 7 Jan, page-113

CUV is of interest to me.  New breakout with a fresh catalyst on expanding volume, all indicators are flashing green. 

Last Price: $20
Symmetrical Triangle Projection: $34

Today CUV had news regarding the expedition of FDA approval - which - had up until today been unforeseen even to management. They're the only company in the world who targets this disease (extreme sensitivity to UV light). the FDA have chosen to expedite the process as they believe it has serious potential at helping many patients in need in their country. This will be game changing for CUV imo.